Investor's Business Daily on MSN
IBD rating upgrades: Moderna flashes improved price strength
Moderna posted 0% earnings growth in the latest quarterly report. Revenue increased -45%. Moderna earns the No. 356 rank among its peers in the Medical-Biomed/Biotech industry gro ...
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, causes chronic (long-term) inflammation and leads to symptoms like frequent diarrhea, abdominal pain, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results